<html>
<head>
    <script language="JavaScript" src="http://code.jquery.com/jquery-1.4.4.js"></script>
    <script language="JavaScript" src="../js/pie.js"></script>
    <script language="JavaScript" src="../js/browser_adjust.js"></script>
    <script language="JavaScript" src="../js/search.js"></script>


    <script type="text/JavaScript">
    <!--

    var array = [[9.8717764359, "../topics/{product,_candidate,_development}.html", "{product,_candidate,_development}"], [6.5163308328, "../topics/{stock,_price,_share}.html", "{stock,_price,_share}"], [3.8350235304, "../topics/{provision,_law,_control}.html", "{provision,_law,_control}"], [3.6201218488, "../topics/{property,_intellectual,_protect}.html", "{property,_intellectual,_protect}"], [2.6627506173, "../topics/{interest,_director,_officer}.html", "{interest,_director,_officer}"], [2.4533917552, "../topics/{competitive,_industry,_competition}.html", "{competitive,_industry,_competition}"], [1.7753134946, "../topics/{acquisition,_growth,_future}.html", "{acquisition,_growth,_future}"], [1.7480590364, "../topics/{product,_liability,_claim}.html", "{product,_liability,_claim}"], [1.6976075938, "../topics/{personnel,_key,_retain}.html", "{personnel,_key,_retain}"], [1.6975528115, "../topics/{cost,_regulation,_environmental}.html", "{cost,_regulation,_environmental}"], [1.6968379477, "../topics/{cost,_operation,_labor}.html", "{cost,_operation,_labor}"], [1.6958773749, "../topics/{control,_financial,_internal}.html", "{control,_financial,_internal}"], [1.6597956569, "../topics/{regulation,_government,_change}.html", "{regulation,_government,_change}"]];
    var elements = generate_pie_elements(array);
    var piec = null;
    function init() {
        browser_adjust();
        
        // create pie chart
        piec = new PieChart(elements);
        piec.initialize();

    }

    function highlight(i) {
        piec.highlight(i);
    }
    
    function unhighlight() {
        piec.unhighlight();
    }
    //-->
    </script>

    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    
    <title>1390478--4/15/2008--RXI_PHARMACEUTICALS_CORP</title>

    <link href="../styling.css" rel="stylesheet" type="text/css">
</head>

<body onLoad="init()">
<div id="navigation">
<hr noshade>
<table><tr>
    <td class="navtext">Browse&nbsp;&#x25B8;</td> 
    <td class="linked"><a>Topics</a>
      <ul> 
        <li><a href="../browse/topic-list.html">List of Terms</a></li> 
        <li><a href="../browse/topic-graph.html">Term Distributions</a></li> 
        <li><a href="../browse/topic-presence.html">Relative Presence</a></li>
      </ul> 
    </td> 
    <td class="linked"><a>Documents</a>
      <ul>
        <li><a href="../browse/doc-graph.html">Topic Distributions</a></li>
      </ul> 
    </td>
    <td class="linked"><a>Terms</a>
      <ul> 
        <li><a href="../browse/term-list.html">List by Frequency</a></li> 
        <li><a href="../browse/term-graph.html">Topic Distributions</a></li> 
       </ul> 
    </td>
    <td class="linked"><a>About</a>
      <ul>
        <li><a href="http://www.cs.princeton.edu/~blei/lda-c/">LDA</a></li>
      </ul> 
    </td>
    
    </td>
    <td></td>
    <td class="searchbar"> Search&nbsp;&#x25B8;</td>
    <td class="searchbar"><input type="text" name="search" size="20" onkeypress="handleKeyPress(event)"><span onclick="doSearch()"></span>
    </td>
</tr></table>
</div>

    <div id="top"></div>

    <h1 id="header">
        <table><tr>
            <td id="title">1390478--4/15/2008--RXI_PHARMACEUTICALS_CORP</td>
        </tr></table>

        <hr noshade>
    </h1>

    <div id="main">
        <table><tr>
            <td width="210px">
                <table class="dark">
                <tr><td><canvas id="canvas" width="200" height="200"></canvas></td></tr>
                <tr class="title">
                    <td>related topics</td>
                </tr>
                <tr class="list"><td id="{product,_candidate,_development}" onmouseover="highlight(0)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_candidate,_development}.html'">{product, candidate, development}</td></tr>
<tr class="list"><td id="{stock,_price,_share}" onmouseover="highlight(1)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_share}.html'">{stock, price, share}</td></tr>
<tr class="list"><td id="{provision,_law,_control}" onmouseover="highlight(2)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{provision,_law,_control}.html'">{provision, law, control}</td></tr>
<tr class="list"><td id="{property,_intellectual,_protect}" onmouseover="highlight(3)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{property,_intellectual,_protect}.html'">{property, intellectual, protect}</td></tr>
<tr class="list"><td id="{interest,_director,_officer}" onmouseover="highlight(4)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{interest,_director,_officer}.html'">{interest, director, officer}</td></tr>
<tr class="list"><td id="{competitive,_industry,_competition}" onmouseover="highlight(5)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{competitive,_industry,_competition}.html'">{competitive, industry, competition}</td></tr>
<tr class="list"><td id="{acquisition,_growth,_future}" onmouseover="highlight(6)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{acquisition,_growth,_future}.html'">{acquisition, growth, future}</td></tr>
<tr class="list"><td id="{product,_liability,_claim}" onmouseover="highlight(7)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_liability,_claim}.html'">{product, liability, claim}</td></tr>
<tr class="list"><td id="{personnel,_key,_retain}" onmouseover="highlight(8)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{personnel,_key,_retain}.html'">{personnel, key, retain}</td></tr>
<tr class="list"><td id="{cost,_regulation,_environmental}" onmouseover="highlight(9)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{cost,_regulation,_environmental}.html'">{cost, regulation, environmental}</td></tr>
<tr class="list"><td id="{cost,_operation,_labor}" onmouseover="highlight(10)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{cost,_operation,_labor}.html'">{cost, operation, labor}</td></tr>
<tr class="list"><td id="{control,_financial,_internal}" onmouseover="highlight(11)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{control,_financial,_internal}.html'">{control, financial, internal}</td></tr>
<tr class="list"><td id="{regulation,_government,_change}" onmouseover="highlight(12)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_government,_change}.html'">{regulation, government, change}</td></tr>

                </table>
            </td>

            <td>
                <table class="light">
                <tr class="doc"><td>
                    We will be subject to competition and may not be able to compete successfully.
We may not be able to maintain the third party relationships that are necessary to develop or potentially commercialize some or all of our product candidates.
We will rely upon third parties for the manufacture of our clinical product candidates.
Any drug candidates we develop may fail in development or be delayed or may not be commercially viable.
The FDA approval process may be delayed for any drugs we develop that require the use of specialized drug delivery devices or vehicles.
If we are not successful in developing pre-clinical product candidates, we will not be able to commence clinical trials in humans or obtain approval for our product candidates.
If our pre-clinical testing does not produce successful results or our clinical trials do not demonstrate safety and efficacy in humans, we will not be able to commercialize our drug candidates.
Even if we obtain regulatory approvals, our marketed drugs will be subject to ongoing regulatory review. If we fail to comply with continuing U.S. and foreign regulations, we could lose our approvals to market drugs and our business would be materially adversely affected.
Even if we receive regulatory approval to market our product candidates, our product candidates may not be accepted commercially, which may prevent us from becoming profitable.
We may be unable to protect our intellectual property rights licensed from UMMS or others, our intellectual property rights may be inadequate to prevent third parties from using our technologies or developing competing products, and we may need to license additional intellectual property from others.
Other companies or organizations may assert patent rights that prevent us from developing our products.
We are dependent on technologies we license, and if we lose the right to license such technologies or we fail to license new technologies in the future, our ability to develop new products would be harmed.
We are subject to potential liabilities from clinical testing and future product liability claims.
Any drugs we develop may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which could have a material adverse effect on our business.
If we fail to attract, hire and retain qualified personnel, we may not be able to design, develop, market or sell our products or successfully manage our business.
We use biological and hazardous materials and if we do not comply with laws regulating the protection of the environment and health and human safety, our business could be adversely affected.
Risks Relating to a Publicly Traded Company and Future Financing Needs
We may be unable to achieve some or all of the benefits that we expected to achieve from our separation from CytRx or to maintain the benefits we previously had as a combined company.
You may have difficulty evaluating our business, because we have no history as a separate company and our historical financial information may not be representative of our results as a separate company.
We may not be able to effectively operate as a separate company.
The obligations associated with being an independent public company will require significant resources and management attention.
We may not be able to obtain sufficient financing, and may not be able to develop our product candidates.
Future financing may be obtained through, and future development efforts may be paid for by, the issuance of debt or equity, which may have an adverse effect on our stockholders or may otherwise adversely affect our business.
We expect to continue to incur significant research and development expenses, which may make it difficult for us to attain profitability, and may lead to uncertainty about or as to our ability to continue as a going concern.
Risks Related to Ownership of Our Common Stock
Because there was no public market for our common stock prior to March 12, 2008, the market price and trading volume of our common stock may be volatile
Future sales of our shares by CytRx or UMMS, or the possibility of such sales, could adversely affect our stock price.
We have granted CytRx preemptive rights to acquire shares that we may sell in the future, which may impair our ability to raise funds.
CytRx s ownership of our common stock could delay or prevent a change in corporate control.
CytRx could unilaterally effect a change of control of our company by selling or disposing of our shares owned by it.
Anti-takeover provisions of our certificate of incorporation and by-laws and provisions of Delaware law could delay or prevent a change of control that you may favor.
We may acquire other businesses or form joint ventures that may be unsuccessful and could adversely dilute your ownership of our company.
<p><a href="http://www.sec.gov/Archives/edgar/data/1390478/0000950135-08-002535.txt">Full 10-K form&nbsp;&#x25B8;</a></p>
                </td></tr>
                </table>
            </td>

            <td width="25%">
                <table class="dark">
                <tr class="title">
                    <td>related documents</td>
                </tr>
                <tr class="list"><td onclick="window.location.href='../docs/1390478--3-18-2009--RXI_PHARMACEUTICALS_CORP.html'">1390478--3/18/2009--RXI_PHARMACEUTICALS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1390478--3-31-2010--RXI_PHARMACEUTICALS_CORP.html'">1390478--3/31/2010--RXI_PHARMACEUTICALS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1314052--12-27-2010--ANAVEX_LIFE_SCIENCES_CORP..html'">1314052--12/27/2010--ANAVEX_LIFE_SCIENCES_CORP.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1314052--12-24-2009--ANAVEX_LIFE_SCIENCES_CORP..html'">1314052--12/24/2009--ANAVEX_LIFE_SCIENCES_CORP.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/854222--12-7-2006--INDEVUS_PHARMACEUTICALS_INC.html'">854222--12/7/2006--INDEVUS_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/704562--7-14-2006--PEREGRINE_PHARMACEUTICALS_INC.html'">704562--7/14/2006--PEREGRINE_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1314052--1-13-2009--ANAVEX_LIFE_SCIENCES_CORP..html'">1314052--1/13/2009--ANAVEX_LIFE_SCIENCES_CORP.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/878903--3-22-2007--ALTEON_INC_-DE.html'">878903--3/22/2007--ALTEON_INC_/DE</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/786623--3-27-2008--ADVANCED_VIRAL_RESEARCH_CORP.html'">786623--3/27/2008--ADVANCED_VIRAL_RESEARCH_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1003642--3-12-2009--IMPAX_LABORATORIES_INC.html'">1003642--3/12/2009--IMPAX_LABORATORIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/704562--7-11-2007--PEREGRINE_PHARMACEUTICALS_INC.html'">704562--7/11/2007--PEREGRINE_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1172480--3-7-2006--SANTARUS_INC.html'">1172480--3/7/2006--SANTARUS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1066833--3-30-2007--DOV_PHARMACEUTICAL_INC.html'">1066833--3/30/2007--DOV_PHARMACEUTICAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1109196--3-3-2006--TELIK_INC.html'">1109196--3/3/2006--TELIK_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/12239--3-30-2010--SPHERIX_INC.html'">12239--3/30/2010--SPHERIX_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1109196--3-2-2009--TELIK_INC.html'">1109196--3/2/2009--TELIK_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1109196--3-2-2010--TELIK_INC.html'">1109196--3/2/2010--TELIK_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/927829--3-6-2008--NITROMED_INC.html'">927829--3/6/2008--NITROMED_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1109196--2-28-2007--TELIK_INC.html'">1109196--2/28/2007--TELIK_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/911216--9-13-2006--PALATIN_TECHNOLOGIES_INC.html'">911216--9/13/2006--PALATIN_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/911216--9-29-2008--PALATIN_TECHNOLOGIES_INC.html'">911216--9/29/2008--PALATIN_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/357097--3-7-2008--ISOLAGEN_INC.html'">357097--3/7/2008--ISOLAGEN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/887359--9-13-2006--AASTROM_BIOSCIENCES_INC.html'">887359--9/13/2006--AASTROM_BIOSCIENCES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1464165--5-28-2010--Neurokine_Pharmaceuticals_Inc..html'">1464165--5/28/2010--Neurokine_Pharmaceuticals_Inc.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1172480--3-6-2007--SANTARUS_INC.html'">1172480--3/6/2007--SANTARUS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1476170--9-28-2010--Unilife_Corp.html'">1476170--9/28/2010--Unilife_Corp</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/887359--9-13-2007--AASTROM_BIOSCIENCES_INC.html'">887359--9/13/2007--AASTROM_BIOSCIENCES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/743884--3-17-2008--MACROCHEM_CORP.html'">743884--3/17/2008--MACROCHEM_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1035354--9-26-2008--SENESCO_TECHNOLOGIES_INC.html'">1035354--9/26/2008--SENESCO_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1082554--2-26-2010--UNITED_THERAPEUTICS_Corp.html'">1082554--2/26/2010--UNITED_THERAPEUTICS_Corp</td></tr>

                </table>
            </td>
        </tr></table>
    </div>

    <div id="footer">
        <br>
        <hr noshade>
    </div>
</body>
</html>
